Capricor Therapeutics Inc (CAPR)

NASDAQ HEALTHCARE
$33.98 -3.19% RSI 49 Neutral Add Alert

Moving Averages

SMA 200
$15.97
Price above

Company Profile

Capricor Therapeutics, Inc., a biotechnology company, focuses on the development of transformative cell- and exosome-based therapies for the treatment and prevention of a broad spectrum of diseases. The company is headquartered in Beverly Hills, California.

Sector
HEALTHCARE
Industry
BIOTECHNOLOGY
Market Cap
$1.79B
P/E Ratio
None
EPS
$-2.26
Beta
0.477
Dividend Yield
0.00%
52-Week High
$40.37
52-Week Low
$4.3

Similar stocks in BIOTECHNOLOGY

BNTX
BioNTech SE
RSI 57.0
VRTX
Vertex Pharmaceuticals Inc
RSI 41.0
CRSP
CRISPR Therapeutics AG
RSI 50.0
MRNA
Moderna Inc
RSI 36.0
VKTX
Viking Therapeutics Inc
RSI 38.0
SRPT
Sarepta Therapeutics Inc
RSI 51.0

Data last updated: April 11, 2026 at 8:28 PM EDT

Track CAPR for free

Get e-mail RSI alerts when Capricor Therapeutics Inc enters oversold or overbought territory. Free forever.

Add Alert